HORIZON FLEXIBLE INCOME ETF (FLXN) Stock Price, Forecast & Analysis

USA • NYSE Arca • NYSEARCA:FLXN • US44053A5231

25.66 USD
+0.11 (+0.45%)
Last: Feb 6, 2026, 08:04 PM
Overview Stock Chart Technical Analysis News

FLXN Key Statistics, Chart & Performance

Key Statistics
Market Cap1.29B
Revenue(TTM)N/A
Net Income(TTM)N/A
Shares50.27M
Float47.41M
52 Week HighN/A
52 Week LowN/A
Yearly DividendN/A
Dividend Yield0%
EPS(TTM)N/A
PEN/A
Fwd PEN/A
Earnings (Next)03-09
IPO2014-02-12
Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryBiotechnology
FLXN short term performance overview.The bars show the price performance of FLXN in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0.5 1 1.5

FLXN long term performance overview.The bars show the price performance of FLXN in the last 1, 2 and 3 years. 1 year 2 years 3 years

The current stock price of FLXN is 25.66 USD. In the past month the price increased by 0.65%.

HORIZON FLEXIBLE INCOME ETF / FLXN Daily stock chart

FLXN Technical Analysis

ChartMill assigns a technical rating of 3 / 10 to FLXN.


Chartmill TA Rating
Chartmill Setup Rating

FLXN Competitors/Peers

The largest stocks on the US markets in the "Biotechnology" sub-industry
Full List
SymbolCompany NameTechnical RatingFundamental RatingFPEMarket Cap
ABBV ABBVIE INC15.39394.886B
AMGN AMGEN INC17.06206.949B
GILD GILEAD SCIENCES INC17.1189.204B
VRTX VERTEX PHARMACEUTICALS INC23.44121.258B
REGN REGENERON PHARMACEUTICALS16.9182.557B
ALNY ALNYLAM PHARMACEUTICALS INC48.9943.353B
INSM INSMED INC N/A31.961B
BIIB BIOGEN INC13.2229.513B
NTRA NATERA INC N/A28.022B
INCY INCYTE CORP13.5421.279B

Related stock screener links

View all stocks in the Biotechnology Industry | View all stocks in the Health Care Sector | View all stocks on the NYSE Arca Exchange | Find more ETFs on the USA exchanges | Find stocks with similar TA and Setup ratings on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges

HORIZON FLEXIBLE INCOME ETF / FLXN FAQ

Can you describe the business of HORIZON FLEXIBLE INCOME ETF?

Flexion Therapeutics, Inc. operates as a biopharmaceutical company, which engages in the development and commercialization of novel and local therapies. The company is headquartered in Burlington, Massachusetts and currently employs 257 full-time employees. The company went IPO on 2014-02-12. The firm is focused on the discovery, development, and commercialization of therapies for the treatment of patients with musculoskeletal conditions, beginning with osteoarthritis (OA), the common form of arthritis. Its product candidate, ZILRETTA, is the intra-articular (IA) injection indicated for the management of OA knee pain. The company is approved by Food and Drug Administration (FDA) to manage osteoarthritis knee pain. The ZILRETTA is a non-opioid therapy that employs its microsphere technology to provide pain relief. The company markets ZILRETTA to prescribing physicians through its own field sales force of Musculoskeletal Business Managers (MBMs). The firm's other product candidates include FX201 and FX301. The FX201 is an IA gene therapy product candidate in clinical development for the treatment of OA. The FX301 is developed as a locally administered peripheral analgesic nerve block for management of post-operative pain.


What is the current price of FLXN stock?

The current stock price of FLXN is 25.66 USD. The price increased by 0.45% in the last trading session.


What is the ChartMill technical and fundamental rating of FLXN stock?

FLXN has a ChartMill Technical rating of 3 out of 10 and a ChartMill Fundamental rating of 0 out of 10.


Is HORIZON FLEXIBLE INCOME ETF (FLXN) stock a good buy?

This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on FLXN.